OncoSec Medical Incorporated (ONCSQ)

OncoSec Medical Income Statement

Financials in millions USD. Fiscal year is August - July.

Year Ending	TTM	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018
Cost of Revenue	0.99	1.07	1.08	0.99	0.24	0
Gross Profit	-0.99	-1.07	-1.08	-0.99	-0.24	0
Selling, General & Admin	10.88	11.19	14.28	18.31	11.97	18.69
Research & Development	21.77	25.82	34.1	25.1	18.45	17.42
Other Operating Expenses	0.06	0.03	-0	0.19	0.44	0.31
Operating Expenses	32.65	37.01	48.38	43.41	30.42	36.11
Operating Income	-32.65	-37.01	-48.38	-43.41	-30.42	-36.11
Interest Expense	0.05	0.02	0.02	0.01	0	0
Other Expense / Income	-0.03	0.48	-0.82	-0.29	-0.15	3.03
Pretax Income	-32.72	-37.51	-47.58	-43.13	-30.27	-39.14
Income Tax	-3.28	-3.33	-2.41	-0.87	0	0
Net Income	-29.39	-34.18	-45.17	-42.25	-30.28	-39.14
Shares Outstanding (Basic)	3	2	1	1	0	0
Shares Outstanding (Diluted)	3	2	1	1	0	0
Shares Change	44.78%	19.45%	99.00%	134.42%	75.79%	98.73%
EPS (Basic)	-15.23	-19.13	-30.20	-56.22	-94.43	-214.59
EPS (Diluted)	-15.23	-19.13	-30.20	-56.22	-94.43	-214.59
Free Cash Flow	-25.01	-32.38	-42.59	-33.15	-29.01	-23.29
Free Cash Flow Per Share	-9.67	-18.13	-28.48	-44.10	-90.50	-127.69
EBITDA	-31.66	-35.92	-47.3	-42.23	-29.73	-32.43
Depreciation & Amortization	0.94	1.07	1.08	0.99	0.24	0.33
EBIT	-32.59	-36.98	-48.38	-43.22	-29.98	-32.76

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.